SCOPUS 정보 검색 플랫폼

British Journal of Cancer

Volumn 87, Issue 1, 2002, Pages 15-20

A phase I dose-escalating study of Daunoxome, liposomal daunorubicin, in metastatic breast cancer

(7) O'Byrne K J a Thomas, A L a Sharma, R A a DeCatris, M a Shields, F a Beare, S a Steward, W P a

a LEICESTER ROYAL INFIRMARY (United Kingdom)

Author keywords

DaunoXome; Liposomal daunorubicin; Metastatic breast cancer

Indexed keywords

ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; DAUNORUBICIN; DEXAMETHASONE; DOXORUBICIN; STEROID;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; METASTASIS; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; DAUNORUBICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEVER; HUMANS; INFUSIONS, INTRAVENOUS; LIPOSOMES; MIDDLE AGED; NEOPLASM METASTASIS; NEUTROPENIA; TREATMENT OUTCOME;

EID: 0036649205 PISSN: 00070920 EISSN: None Source Type: Journal
DOI: 10.1038/sj.bjc.6600344 Document Type: Article

Times cited : (63)

References (39)

1
- 0027471578
- Chemotherapy and survival in advanced breast cancer: The inclusion of doxorubicin in Cooper type regimens
- (1993) Br J Cancer , vol.67 , pp. 801-805
- A'hern, R.¹ Smith, I.² Ebbs, S.³

2
- 0035282073
- Reduced cardiotoxicity and preserved anti-tumour efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomised, multicenter trial of metastatic breast cancer
- (2001) J Clin Oncol , vol.19 , pp. 1444-1454
- Batist, G.¹ Ramakrishnan, G.² Sekhar Rao, C.³ Chandrasekharan, A.⁴ Gutheil, J.⁵ Guthrie, T.⁶ Shah, P.⁷ Khojasteh, A.⁸ Krishnan Nair, M.⁹ Hoelzer, K.¹⁰ Tkaczuk, K.¹¹ Choi Park, Y.¹² Lee, L.W.¹³

3
- 0034924032
- Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia
- (2001) Cancer Chemother Pharmacol , vol.47 , pp. 15-21
- Bellott, R.¹ Auvrignon, A.² Leblanc, T.³ Perel, Y.⁴ Gandemer, V.⁵ Bertrand, Y.⁶ Mechinaud, F.⁷ Bellenger, P.⁸ Vernois, J.⁹ Leverger, G.¹⁰ Baruchel, A.¹¹ Robert, J.¹²

4
- 0023008109
- New anthracycline analogs in advanced breast cancer
- (1986) Eur J Cancer Clin Oncol , vol.22 , pp. 1379-1385
- Bonfante, V.¹ Ferrari, L.² Brambilla, C.³ Rossi, A.⁴ Villani, F.⁵ Crippa, F.⁶ Valagussa, P.⁷ Bonadonna, G.⁸

5
- 0024355996
- The use of granulocyte colony stimulating factor to increase intensity of treatment with doxorubicin in patients with breast and ovarian cancer
- (1989) Br J Cancer , vol.60 , pp. 121-125
- Bronchud, M.H.¹ Howell, A.² Crowther, D.³ Hopwood, P.⁴ Souza, L.⁵ Dexter, T.M.⁶

6
- 0032857264
- Phase I study of Doxil and vinorelbine in metastatic breast cancer
- (1999) Ann Oncol , vol.10 , pp. 1113-1116
- Burstein, H.J.¹ Ramirez, M.J.² Petros, W.P.³ Clarke, K.D.⁴ Warmuth, M.A.⁵ Marcom, P.K.⁶ Matulonis, U.A.⁷ Parker, L.M.⁸ Harris, L.N.⁹ Winer, E.P.¹⁰

7
- 0021878134
- Early and delayed clinical cardiotoxicity of doxorubicin
- (1985) Cancer , vol.55 , pp. 2761-2765
- Buzdar, A.¹ Marcus, C.² Smith, T.³

8
- 0032787785
- Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer
- (1999) J Clin Oncol , vol.17 , pp. 2341-2354
- Chan, S.¹ Friedrichs, K.² Noel, D.³ Pinter, T.⁴ Van Belle, S.⁵ Vorobiof, D.⁶ Duarte, R.⁷ Gil Gil, M.⁸ Bodrogi, I.⁹ Murray, E.¹⁰ Yelle, L.¹¹ Von Minckwitz, G.¹² Korec, S.¹³ Simmonds, P.¹⁴ Buzzi, F.¹⁵ Gonzalez Mancha, R.¹⁶ Richardson, G.¹⁷ Warpole, E.¹⁸ Ronzoni, M.¹⁹ Murawsky, M.²⁰ Alakl, M.²¹ Riva, A.²² more..

9
- 0032623277
- Administration of liposomal preparation of DaunoXome for breast cancer in patients with poor prognosis
- (1999) Vopr Onkol , vol.45 , pp. 440-444
- Darskaia, E.I.¹ Zubarovskaia, L.S.² Afanas'ev, B.V.³

10
- 0033745652
- A dose-finding study of liposomal daunorubicin with CVP (COP-X) in advanced NHL
- (2000) Ann Oncol , vol.11 , pp. 691-695
- Flinn, I.W.¹ Goodman, S.N.² Post, L.³ Jamison, J.⁴ Miller, C.B.⁵ Gore, S.⁶ Diehl, L.⁷ Willis, C.⁸ Ambinder, R.F.⁹ Byr, J.C.¹⁰

11
- 0026718957
- Selective in vivo localisation of daunorubicin small unilamellar vesicles in solid tumors
- (1992) Cancer Res , vol.52 , pp. 3255-3261
- Forssen, E.A.¹ Coulter, D.M.² Proffitt, R.T.³

12
- 0028204863
- DaunoXome treatment of solid tumors: Preclinical and clinical investigations
- (1994) J Liposome Res , vol.4 , pp. 481-512
- Forssen, E.A.¹ Ross, M.E.²

13
- 0029875698
- Fluoresence imaging studies for the disposition of daunorubicin liposomes (DaunoXome) within tumor tissue
- (1996) Cancer Res , vol.56 , pp. 2066-2075
- Forssen, E.A.¹ MaléBrune, R.² Adler-Moore, J.P.³ Lee, M.J.⁴ Schmidt, P.G.⁵ Krasieva, T.B.⁶ Shimizu, S.⁷ Tromberg, B.J.⁸

14
- 0032101833
- A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma
- (1998) Eur J Cancer , vol.34 , pp. 1131-1132
- Fossa, S.D.¹ Aass, N.² Paro, G.³

15
- 0026603586
- Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes
- (1992) Cancer Res , vol.52 , pp. 891-896
- Gabizon, A.A.¹

16
- 0028920270
- Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin
- (1995) J Clin Oncol , vol.13 , pp. 996-1003
- Gill, P.A.¹ Espina, B.M.² Muggia, F.³ Cabriales, S.⁴ Tulpule, A.⁵ Esplin, J.A.⁶ Liebman, H.A.⁷ Forssen, E.⁸ Ross, M.E.⁹ Levine, A.M.¹⁰

17
- 9444258072
- Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin and vincristine in AIDS-related Kaposi's sarcoma
- (1996) J Clin Oncol , vol.14 , pp. 2353-2364
- Gill, P.S.¹ Wernz, J.² Scadden, D.T.³ Cohen, P.⁴ Mukwaya, G.M.⁵ Von Roenn, J.H.⁶ Jacobs, M.⁷ Kempin, S.⁸ Silverberg, I.⁹ Gonzales, G.¹⁰ Rarick, M.U.¹¹ Myers, A.M.¹² Shepherd, F.¹³ Sawka, C.¹⁴ Pike, M.C.¹⁵ Ross, M.E.¹⁶

18
- 0035879099
- Recurrent epithelial ovarian carcinoma: A randomized phase III study of pegylated liposomal doxorubicin versus topotecan
- (2001) J Clin Oncol , vol.19 , pp. 3312-3322
- Gordon, A.N.¹ Fleagle, J.T.² Guthrie, D.³ Parkin, D.E.⁴ Gore, M.E.⁵ Lacave, A.J.⁶

19
- 0028054331
- Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome)
- (1994) Invest New Drugs , vol.12 , pp. 103-110
- Guaglianone, P.¹ Chan, K.² DelaFlor-Weiss, E.³ Hanisch, R.⁴ Jeffers, S.⁵ Sharma, D.⁶ Muggia, F.⁷

20
- 0021712474
- A phase I study of daunorubicin in advanced untreatable malignancies
- (1984) Sem Oncol , vol.11 , pp. 33-35
- Harvey, J.¹ Goodman, A.² McFadden, M.³ Schein, P.⁴ Smith, F.⁵

21
- 0024520987
- Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer
- (1989) J Clin Oncol , vol.7 , pp. 560-571
- Henderson, I.C.¹ Allegra, J.C.² Woodcock, T.³ Wolff, S.⁴ Bryan, S.⁵ Cartwright, K.⁶ Dukart, G.⁷ Henry, D.⁸

22
- 0030002008
- DaunoXome shows promise as breast cancer treatment
- (1996) Oncology (Huntingt) , vol.10 , pp. 425
- Hupperets¹

23
- 0032580354
- Drug delivery and targeting
- (1998) Nature , vol.392 , pp. 5-10
- Langer, R.¹

24
- 0017108045
- Cardiotoxicity of adriamycin and related anthracyclines
- (1976) Cancer Treat Rev , vol.3 , pp. 111-120
- Lenaz, L.¹ Page, J.A.²

25
- 0024809997
- A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer
- (1989) Cancer , vol.64 , pp. 2431-2436
- Lopez, M.¹ Contegiacomo, A.² Vici, P.³ Dello Ioio, C.⁴ Di Lauro, L.⁵ Pagliarulo, C.⁶ Carpano, S.⁷ Giannarelli, D.⁸ De Placido, S.⁹ Fazio, S.¹⁰ Bianco, A.F.¹¹

26
- 0034049808
- Phase III comparative study of vinorelbine combined with doxorubicin alone in disseminated metastatic/recurrent breast cancer: National cancer institute of canada clinical trials group study MA8
- (2000) J Clin Oncol , vol.18 , pp. 2385-2394
- Norris, B.¹ Prichard, K.I.² James, K.³ Myles, J.⁴ Bennett, K.⁵ Marlin, S.⁶ Skillings, J.⁷ Findlay, B.⁸ Vandenberg, T.⁹ Goss, P.¹⁰ Latreille, J.¹¹ Rudinskas, L.¹² Lofters, W.¹³ Trudeau, M.¹⁴ Osoba, D.¹⁵ Rodgers, A.¹⁶

27
- 0021714793
- Clinical pharmacology of daunorubicin in phase I patients with solid tumors: Development of an analytical methodology for daunorubicin and its metabolites
- (1984) Sem Oncol , vol.11 , pp. 36-44
- Rahman, A.¹ Goodman, A.² Foo, W.³ Harvey, J.⁴ Smith, F.P.⁵ Schein, P.S.⁶

28
- 0021745628
- Potential of liposomes to ameliorate anthracycline-induced cardiotoxicity
- (1984) Sem Oncol , vol.11 , pp. 45-55
- Rahman, A.¹ Furnagalli, A.² Goodman, A.³ Schein, P.S.⁴

29
- 0030959798
- Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: Results of a multicenter phase II trial
- (1997) J Clin Oncol , vol.15 , pp. 3185-3191
- Ranson, M.R.¹ Carmichael, J.² O'Byrne, K.³ Stewart, S.⁴ Smith, D.⁵ Howell, A.⁶

30
- 0030667453
- Early evaluation of liposomal daunorubicin (DaunoXome, Nexstar) in the treatment of relapsed and refractory lymphoma
- (1997) Invest New Drugs , vol.15 , pp. 247-253
- Richardson, D.S.¹ Kelsey, S.M.² Johnson, S.A.³ Tighe, M.⁴ Cavenagh, J.D.⁵ Newland, A.C.⁶

31
- 0035868797
- Phase I study of stealth liposomal doxorubicin in combination with gemcitabine in the treatment of patients with metastatic breast cancer
- (2001) J Clin Oncol , vol.19 , pp. 1716-1722
- Rivera, E.¹ Valero, V.² Syrewicz, L.³ Rahman, Z.⁴ Esteva, F.L.⁵ Theriault, R.L.⁶ Rosales, M.M.⁷ Booser, D.⁸ Murray, J.L.⁹ Bast, R.C.¹⁰ Hortobagyi, G.N.¹¹

32
- 0021248127
- Randomized phase II trial of carminomycin versus 4′-epidoxorubicin in advanced breast cancer
- (1984) J Clin Oncol , vol.2 , pp. 275-281
- Rozencweig, M.¹ Ten Bokkel Huinink, W.² Cavelli, F.³ Bruntsch, U.⁴ Dombernowsky, P.⁵ Host, H.⁶ Bramwell, V.⁷ Renard, G.⁸ Van Glabbeke, M.⁹ Decoster, G.¹⁰

33
- 0021687876
- Cardiac effects of anthracyclines used in the treatment of childhood acute lymphoblastic leukemia: A 10-year experience
- (1984) Sem Oncol , vol.11 , pp. 19-21
- Sallan, S.E.¹ Clavell, L.A.²

34
- 0023617324
- Continuous venous infusion of doxorubicin in advanced sarcomas
- (1987) Cancer Treat Rep , vol.71 , pp. 971-976
- Samuels, B.L.¹ Vogelzang, N.J.² Ruane, M.³ Simon, M.A.⁴

35
- 0033670039
- Liposomal doxorubicin and weekly paclitaxel in the treatment of metastatic breast cancer
- (2000) Anticancer Drugs , vol.11 , pp. 681-685
- Schwonzen, M.¹ Kurbacher, C.M.² Mallmann, P.³

36
- 0035869407
- Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2
- (2001) N Engl J Med , vol.344 , pp. 783-792
- Slamon, D.J.¹ Leyland-Jones, B.² Shak, S.³ Fuchs, H.⁴ Paton, V.⁵ Bajamonde, A.⁶ Fleming, T.⁷ Eiermann, W.⁸ Wolter, J.⁹ Pegram, M.¹⁰ Baselga, J.¹¹ Norton, L.¹²

37
- 0002088796
- Phase III trial of doxorubicin (A) vs. doxorubicin + paclitaxel (A+T) as first-line therapy for metastatic breast cancer (MBC): An Intergroup trial
- (1997) Proc Am Soc Clin Oncol , vol.16 , pp. 2
- Sledge, G.W.¹ Neuberg, D.² Ingle, J.³ Martino, S.⁴ Wood, W.⁵

38
- 0021674047
- Use of daunorubicin in patients with solid tumors
- (1984) Sem Oncol , vol.11 , pp. 23-27
- Von Hoff, D.D.¹

39
- 0031414404
- Anthracycline efficacy in vitro: Cytotoxicity of Liposomal/Nonliposomal daunorubicin and doxorubicin for multiple tumor cell types
- (1997) Drug Del , vol.4 , pp. 255-262
- Wiles, M.E.¹ Bell, C.² Landfair, D.³ Lyman, E.⁴ Bendele, R.A.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.